| Genomic hallmarks of localized, non-indolent prostate cancer M Fraser, VY Sabelnykova, TN Yamaguchi, LE Heisler, J Livingstone, ... Nature 541 (7637), 359-364, 2017 | 494 | 2017 |
| Molecular landmarks of tumor hypoxia across cancer types V Bhandari, C Hoey, LY Liu, E Lalonde, J Ray, J Livingstone, R Lesurf, ... Nature genetics 51 (2), 308-318, 2019 | 378 | 2019 |
| Widespread and functional RNA circularization in localized prostate cancer S Chen, V Huang, X Xu, J Livingstone, F Soares, J Jeon, Y Zeng, JT Hua, ... Cell 176 (4), 831-843. e22, 2019 | 292 | 2019 |
| Germline BRCA2 mutations drive prostate cancers with distinct evolutionary trajectories RA Taylor, M Fraser, J Livingstone, SMG Espiritu, H Thorne, V Huang, ... Nature communications 8 (1), 13671, 2017 | 186 | 2017 |
| The evolutionary landscape of localized prostate cancers drives clinical aggression SMG Espiritu, LY Liu, Y Rubanova, V Bhandari, EM Holgersen, LM Szyca, ... Cell 173 (4), 1003-1013. e15, 2018 | 185 | 2018 |
| A robust benchmark for detection of germline large deletions and insertions JM Zook, NF Hansen, ND Olson, L Chapman, JC Mullikin, C Xiao, ... Nature biotechnology 38 (11), 1347-1355, 2020 | 184 | 2020 |
| TMPRSS2–ERG fusion co-opts master transcription factors and activates NOTCH signaling in primary prostate cancer KJ Kron, A Murison, S Zhou, V Huang, TN Yamaguchi, YJ Shiah, M Fraser, ... Nature genetics 49 (9), 1336-1345, 2017 | 158 | 2017 |
| Pan-cancer analysis of whole genomes. S Hirano, L Yang, M Juul, CA Purdie, BP O'Neill, R Kabbe, ... Nature 578 (DKFZ-2020-01051), 82-93, 2020 | 152 | 2020 |
| The proteogenomic landscape of curable prostate cancer A Sinha, V Huang, J Livingstone, J Wang, NS Fox, N Kurganovs, ... Cancer Cell 35 (3), 414-427. e6, 2019 | 141 | 2019 |
| Cribriform and intraductal prostate cancer are associated with increased genomic instability and distinct genomic alterations R Böttcher, CF Kweldam, J Livingstone, E Lalonde, TN Yamaguchi, ... BMC cancer 18 (1), 1-11, 2018 | 95 | 2018 |
| Long non-coding RNA urothelial carcinoma associated 1 (UCA1) mediates radiation response in prostate cancer AF Ghiam, S Taeb, X Huang, V Huang, J Ray, S Scarcello, C Hoey, ... Oncotarget 8 (3), 4668, 2017 | 76 | 2017 |
| A robust benchmark for germline structural variant detection JM Zook, NF Hansen, ND Olson, LM Chapman, JC Mullikin, C Xiao, ... BioRxiv, 664623, 2019 | 61 | 2019 |
| Noncoding mutations target cis-regulatory elements of the FOXA1 plexus in prostate cancer S Zhou, JR Hawley, F Soares, G Grillo, M Teng, SA Madani Tonekaboni, ... Nature communications 11 (1), 441, 2020 | 55 | 2020 |
| Candidate cancer driver mutations in distal regulatory elements and long-range chromatin interaction networks H Zhu, L Uusküla-Reimand, K Isaev, L Wadi, A Alizada, S Shuai, V Huang, ... Molecular cell 77 (6), 1307-1321. e10, 2020 | 51 | 2020 |
| Genome-wide germline correlates of the epigenetic landscape of prostate cancer KE Houlahan, YJ Shiah, A Gusev, J Yuan, M Ahmed, A Shetty, ... Nature medicine 25 (10), 1615-1626, 2019 | 49 | 2019 |
| Molecular hallmarks of multiparametric magnetic resonance imaging visibility in prostate cancer KE Houlahan, A Salmasi, TY Sadun, A Pooli, ER Felker, J Livingstone, ... European urology 76 (1), 18-23, 2019 | 48 | 2019 |
| Cistrome partitioning reveals convergence of somatic mutations and risk variants on master transcription regulators in primary prostate tumors P Mazrooei, KJ Kron, Y Zhu, S Zhou, G Grillo, T Mehdi, M Ahmed, ... Cancer Cell 36 (6), 674-689. e6, 2019 | 41 | 2019 |
| Combining accurate tumor genome simulation with crowdsourcing to benchmark somatic structural variant detection AY Lee, AD Ewing, K Ellrott, Y Hu, KE Houlahan, JC Bare, SMG Espiritu, ... Genome biology 19, 1-15, 2018 | 39 | 2018 |
| Comparison between corticosteroid and lidocaine injection in the treatment of tennis elbow: a randomized, double-blinded, controlled trial LF Hsieh, YC Kuo, CC Lee, YF Liu, YC Liu, V Huang American journal of physical medicine & rehabilitation 97 (2), 83-89, 2018 | 24 | 2018 |
| Candidate cancer driver mutations in superenhancers and long-range chromatin interaction networks L Wadi, L Uusküla-Reimand, K Isaev, S Shuai, V Huang, M Liang, ... BioRxiv, 236802, 2017 | 7 | 2017 |
